| Code | 3250D | ||||||||||
| MA number | EU/1/98/066/044 | ||||||||||
| Product Form: | emp tdm 30x13,3 mg/24 hodín (vre.pap.PET/PE/Al/PA) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Novartis Europharm Limited, Ireland | ||||||||||
| Therapeutic Class: | 06 - PSYCHOSTIMULANTIA (NOOTROPNE LIEČ., ANALEPTIKA) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Transdermal use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application |
| MA issued: | 12.05.1998 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
Exelon_TTS_DHPC.pdf
|
| Dokument: |
Exelon_Pacientsky_dennik.pdf
|
| Safety feature | Yes |
| Data update: | 27.01.2022 |
